Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.08
+0.10 (1.25%)
At close: Sep 15, 2025, 4:00 PM EDT
8.09
+0.01 (0.12%)
After-hours: Sep 15, 2025, 7:59 PM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,133,107
Profits / Employee
$444,143
Market Cap
1.31B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 952 | -591 | -38.30% |
| Dec 31, 2023 | 1,543 | -449 | -22.54% |
| Dec 31, 2022 | 1,992 | 451 | 29.27% |
| Dec 31, 2021 | 1,541 | 749 | 94.57% |
| Dec 31, 2020 | 792 | 624 | 371.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVAX News
- 11 days ago - Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 11 days ago - Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment - PRNewsWire
- 12 days ago - Novavax to Participate in the Cantor Global Healthcare Conference - PRNewsWire
- 19 days ago - Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. - PRNewsWire
- 25 days ago - Novavax Announces Convertible Debt Refinancing - PRNewsWire
- 5 weeks ago - Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Novavax beats quarterly revenue estimates on milestone payment - Reuters
- 5 weeks ago - Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights - PRNewsWire